Cargando…

Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune responses, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). The treatment options for AILD remain limited, and the adverse side effects of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chengmei, Yang, Yanlei, Zheng, Kunyu, Chen, Yiran, Liu, Suying, Li, Yongzhe, Han, Qin, Zhao, Robert Chunhua, Wang, Li, Zhang, Fengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887681/ https://www.ncbi.nlm.nih.gov/pubmed/33633826 http://dx.doi.org/10.1177/2040622321993442

Ejemplares similares

Long Non-coding RNA Regulation of Mesenchymal Stem Cell Homeostasis and Differentiation: Advances, Challenges, and Perspectives
por: Yang, Yanlei, et al.
Publicado: (2021)

LncRNA LYPLAL1-AS1 rejuvenates human adipose-derived mesenchymal stem cell senescence via transcriptional MIRLET7B inactivation
por: Yang, Yanlei, et al.
Publicado: (2022)

Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
por: Yang, Yanlei, et al.
Publicado: (2022)

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
por: Li, Chunlei, et al.
Publicado: (2022)

EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
por: He, Chengmei, et al.
Publicado: (2022)

CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC
por: Chen, Zhilei, et al.
Publicado: (2021)

Animal models of primary biliary cholangitis: status and challenges
por: Wang, Xu, et al.
Publicado: (2023)

Ten-year survival analysis of patients with primary Sjögren’s syndrome in China: a national prospective cohort study
por: Qian, Junyan, et al.
Publicado: (2021)

Long noncoding RNA LYPLAL1-AS1 regulates adipogenic differentiation of human mesenchymal stem cells by targeting desmoplakin and inhibiting the Wnt/β-catenin pathway
por: Yang, Yanlei, et al.
Publicado: (2021)

Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges
por: Gonçalves, Renata Guedes de Jesus, et al.
Publicado: (2022)

Stem Cell Therapies for Human Infertility: Advantages and Challenges
por: Wu, Jin-Xiang, et al.
Publicado: (2022)

Serum IgG Subclasses in Autoimmune Diseases
por: Zhang, Haoze, et al.
Publicado: (2015)

Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
por: Sani, Farnaz, et al.
Publicado: (2023)

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease
por: Zhang, Shulan, et al.
Publicado: (2018)

Advantages and challenges of stem cell therapy for osteoarthritis (Review)
por: Loo, Stephanie Jyet Quan, et al.
Publicado: (2021)

Long noncoding RNA ANCR inhibits the differentiation of mesenchymal stem cells toward definitive endoderm by facilitating the association of PTBP1 with ID2
por: Li, Jing, et al.
Publicado: (2019)

Mesenchymal stem cells, autoimmunity and rheumatoid arthritis
por: El-Jawhari, J.J., et al.
Publicado: (2014)

Mesenchymal stem cells for treating autoimmune dacryoadenitis
por: Lu, Xiaoxiao, et al.
Publicado: (2017)

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021)

The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases
por: Lee, Seoung Hoon
Publicado: (2018)

Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages
por: Kim, Hee Jung, et al.
Publicado: (2017)

Human Adipose Mesenchymal Stem Cell-derived Exosomes Protect Mice from DSS-Induced Inflammatory Bowel Disease by Promoting Intestinal-stem-cell and Epithelial Regeneration
por: Yu, Hongliang, et al.
Publicado: (2021)

Lnc13728 facilitates human mesenchymal stem cell adipogenic differentiation via positive regulation of ZBED3 and downregulation of the WNT/β-catenin pathway
por: Xu, Haoying, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for liver disease: full of chances and challenges
por: Yang, Xue, et al.
Publicado: (2020)

Radiolabeling of Nanomaterials: Advantages and Challenges
por: Dai, Wanqin, et al.
Publicado: (2021)

Mesenchymal stem cells in autoimmune diseases: hype or hope?
por: Scherer, Hans U, et al.
Publicado: (2010)

Comparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse model
por: Song, Guang, et al.
Publicado: (2013)

Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis
por: Bai, Lingling, et al.
Publicado: (2017)

Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis
por: Deng, Chuiwen, et al.
Publicado: (2016)

Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases
por: Shen, Ziwei, et al.
Publicado: (2021)

Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases
por: Zaripova, Lina N., et al.
Publicado: (2023)

Learning from Cases: Advantages and Challenges
por: Rodriguez, L. Leonardo, et al.
Publicado: (2021)

Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities
por: Lin, Weiping, et al.
Publicado: (2019)

Therapeutic Efficacy of Mesenchymal Stem Cells and Mesenchymal Stem Cells-derived Neural Progenitors in Experimental Autoimmune Encephalomyelitis
por: Nasri, Fatemeh, et al.
Publicado: (2018)

Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases
por: Yan, Li, et al.
Publicado: (2018)

Stimulation of chondrocytes and chondroinduced mesenchymal stem cells by osteoinduced mesenchymal stem cells under a fluid flow stimulus on an integrated microfluidic device
por: Bao, Xuanwen, et al.
Publicado: (2018)

Clinical applications of mesenchymal stem cells
por: Wang, Shihua, et al.
Publicado: (2012)

The effect and the mechanism of allo-bone marrow mesenchymal stem cells in experimental autoimmune thyroiditis
por: Zheng, Rongxiu, et al.
Publicado: (2015)

Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases
por: Li, Zhiliang, et al.
Publicado: (2018)

The role of mesenchymal stem cells in liver injury
por: Sun, Haoyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_njj3vhi60c6nbugt14frh1oiin